Trapping Methylglyoxal by Myricetin and Its Metabolites in Mice

摘要

Trapping of methylglyoxal (MGO) has been determined to be one of the potential mechanisms for dietary polyphenols to prevent chronic diseases. In this study, myricetin was demonstrated to efficiently trap MGO to generate mono- and di-MGO adducts under in vitro conditions. Furthermore, the mono- and di-MGO adducts of myricetin were detected in urine and fecal samples collected from myricetin-treated mice based on LC-MS analysis. More importantly, the mono-MGO adducts of the mono- and di-methylated myricetin were also found in these mouse samples. Further dose-dependent studies demonstrated that myricetin and its methylated metabolites significantly trapped MGO in a dose-dependent manner with the 400 mg/kg dose having the highest trapping efficacy (mono-MGO-myricetin: 272.0 +/- 90.9 nM in urine and 1.05 +/- 0.67 mu g/g in feces; mono-MGO-monoMe-myricetin: 135.2 +/- 77.6 nM in urine and 1.16 +/- 0.65 mu g/g in feces; and mono-MGO-di-Me-myricetin: 17.0 +/- 5.9 nM in urine and 0.19 +/- 0.04 mu g/g in feces) compared to the 100 and 200 mg/kg doses. In conclusion, this study demonstrates for the first time the in vivo trapping efficacy of myricetin, suggesting that intake of myricetin-containing foods has the potential to scavenge MGO in vivo and to prevent MGO-induced harmful effects to human health.